# Contact Tesarx: Editorial Inquiries on the Tesamorelin Record

> Contact Tesarx with editorial questions or corrections about our tesamorelin literature summaries. We do not provide medical advice and we do not sell any product.

Editorial questions, source suggestions, and corrections to our tesamorelin summaries are welcome.

## Editorial inquiries

Tesarx is an editorial digest of the peer-reviewed tesamorelin literature. If you have spotted an error, want to suggest a study we have missed, or have a question about how we summarized a finding, the form below reaches the editorial desk.

We respond to editorial and source-related correspondence. We do not provide medical advice, we do not answer individual health questions, and we do not offer consultations. For anything concerning your own health, a qualified healthcare professional is the right contact, not this site.

## What we do not do

We do not sell, source, price, or distribute tesamorelin or any other product, and we cannot direct you to a supplier. We are not a clinic or a pharmacy, and we hold no prescribing role. Messages asking to purchase the compound or requesting dosing guidance cannot be answered.

What we can help with: clarifying a citation, correcting a figure, or pointing to the study behind a claim. The record is the subject here, and keeping it accurate is the work.

## Send a message

Use the form to reach the editorial team. Include the page and the specific claim or citation you are writing about so we can trace it back to the source quickly. We read every message, though we cannot guarantee an individual reply to non-editorial correspondence.

---

Tesarx files the tesamorelin record as a flat, hard-bordered data sheet — every visceral-fat and IGF-1 figure logged straight to its study, the lone HIV-lipodystrophy approval and the off-label edge ruled in plain view; an exposed-document digest, never a clinic, a pharmacy, or a prescription.